In the last month they reported on the potential roll out of Excellagen in Asia and they signed a contract with a vendor to manage the clinical development of their vaccine candidate. And keeping in mind that as an underfunded pip-squeak company the concept of ‘time’ is so elastic that it seems like an hallucinogenic dream? I only ask my esteemed fellow boardsters: why would they announce these two developments if they weren’t progressing down these respective and concurrent paths? Like Joe or hate him, I believe GNBT and NGIO are actually moving forward daaaay by daaaay.